WT1 和 PRAME RNA 负载的树突状细胞疫苗作为新发 AML 强化诱导化疗后的维持治疗
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.
47.2分
★★★☆☆
站内排序·非疗效
ALL SOURCES
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.
Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasms.
Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review.
我们进行了一项系统综述,支持将 DC 疫苗疗法作为 AML 的有效治疗方法。该疗法在实现缓解、增强免疫系统功能和延长总生存期方面显示出潜力。然而,需要更多研究来改进 DC 疫苗的制备和递送方法,并确认其长期安全性和有效性。
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。